Safety Study of A-101 Topical Solution for the Treatment of Common Warts

NCT03812510 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
426
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Aclaris Therapeutics, Inc.